AT
AeroRx Therapeutics, Inc.
SEC filingOther Health Care · LA Jolla, CA
Amount raised$10.4Msold at filing
Total offering$20.8M$10.4M still open
Investors in the raise17count reported to the SEC
FiledOct 10, 2025first sale Sep 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ahmet Tutuncu, M.D., Ph.D.Executive Officer, Director
Tighe ReardonExecutive Officer
Heather Stuart Preston, M.D.Director
Jay B. Lichter, Ph.D.Director
John Stuart Patton, Ph.D.Director
Sanford Madigan, Ph.D.Director
Executive officers, directors and promoters as listed on the Form D.